bioAffinity Technologies Inc. (BIAF): Price and Financial Metrics
BIAF Price/Volume Stats
Current price | $2.91 | 52-week high | $3.62 |
Prev. close | $2.83 | 52-week low | $0.95 |
Day low | $2.89 | Volume | 209,500 |
Day high | $3.10 | Avg. volume | 180,642 |
50-day MA | $2.03 | Dividend yield | N/A |
200-day MA | $1.68 | Market Cap | 33.51M |
BIAF Stock Price Chart Interactive Chart >
Latest BIAF News From Around the Web
Below are the latest news stories about BIOAFFINITY TECHNOLOGIES INC that investors may wish to consider to help them evaluate BIAF as an investment opportunity.
bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of DirectorsSAN ANTONIO, December 05, 2023--Jamie Platt, Ph.D., joins the bioAffinity Technologies Board of Directors |
CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024SAN ANTONIO,, November 30, 2023--CMS has made a final determination for payment for CyPath® Lung, a noninvasive test for early-stage lung cancer, for the 2024 calendar year. |
bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology PostSAN ANTONIO, November 28, 2023--bioAffinity Technologies VP of Research David Elzi, Ph.D., named to post with the American Society for Cell Biology |
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer ScreeningSAN ANTONIO, Texas, November 15, 2023--bioAffinity Technologies today launched a campaign in partnership with the ACS to increase lung cancer screening in Texas. |
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateSAN ANTONIO, November 14, 2023--bioAffinity Technologies reports third quarter 2023 financial results and provides business update. |
BIAF Price Returns
1-mo | 40.58% |
3-mo | 88.96% |
6-mo | 102.07% |
1-year | 60.77% |
3-year | N/A |
5-year | N/A |
YTD | 97.89% |
2023 | -8.09% |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...